跳至主要内容
临床试验/ACTRN12620000599976
ACTRN12620000599976已完成3 期

Topical corticosteroid for treatment of hand osteoarthritis

Flavia Cicuttini0 个研究点目标入组 106 人开始时间: 2020年5月22日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
106

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
40 Years 至 o limit(—)
性别
All

入选标准

  • 1. Participants aged >40 years with symptomatic radiological hand osteoarthritis;
  • 2. Pain score of at least 40 on a 100 mm visual analogue scale and radiological OA (Kellgren and Lawrence grade >=2) in >=1 joint;
  • 3. Stable analgesic requirements (including non-steroidal anti-inflammatory drugs) for at least 4 weeks, stable doses of chondroitin or glucosamine for 4 months, no corticosteroids via any route for at least 3 months.

排除标准

  • 1. Concomitant rheumatic disease, inflammatory joint disease, psoriatic arthritis, ankylosing spondylitis, or gout;
  • 2. Allergic reaction to other medicines containing betamethasone dipropionate, any other corticosteroid(s), or any of the ingredients of Diprosone OV ointment (i.e. betamethasone as dipropionate, propylene glycol, white beeswax, propylene glycol monostearate, and soft white paraffin);
  • 3. Contraindication to topical corticosteroids (e.g. untreated bacterial, fungal, or viral skin lesions; widespread plaque psoriasis; skin conditions with ulcers);
  • 4. Unable to complete informed consent;
  • 5. Pregnancy, breast feeding, or trying to become pregnant.

研究者

发起方
Flavia Cicuttini

相似试验